What are the general steps involved in pharmaceutical stability testing under ICH guidelines?

• A. Define stability protocol; perform real-time and accelerated studies; store under specified conditions; analyze potency, impurities, and physical stability; interpret data to establish shelf-life and storage conditions.
• B. Randomly select samples and test once.
• C. Only test under accelerated conditions and ignore real-time.
• D. Focus only on potency, ignoring impurities and physical stability.

Answer: (A)

Stability testing under ICH centers on designing a stability program that sets a protocol with defined storage conditions, time points, and acceptance criteria, and then gathering data from both long-term real-time and accelerated studies. Samples are stored under specified conditions that reflect realistic and potential stress environments, and at planned intervals they are analyzed with validated, stability-indicating methods to monitor potency, impurities/degradation products, and physical stability (such as appearance, crystallinity, or dissolution when relevant). The resulting data are interpreted to estimate the product’s shelf-life and recommended storage conditions, informing labeling and regulatory decisions. This comprehensive approach ensures quality is tracked over time, not just at a single snapshot.

Testing randomly once misses time-based trends; relying only on accelerated conditions ignores how the product behaves in real time; focusing solely on potency neglects impurities and physical stability that signal degradation.